Metastatic solid tumors to the testis: a clinicopathologic evaluation of 157 cases from an international collaboration
Kiril Trpkov,Allaume Pierre,Angela Chou,Asli Yilmaz,Aurélien Morini,Ângelo Rodrigues,Delia Perez-Montiel,Fiona Maclean,Félix Contreras,Francisco Javier Queipo,Gorka Muñiz Unamunzaga,Hector Mesa,Inés de Torres,Irune Ruiz,Isabel Alvarado-Cabrero,João Lobo,Lauren Schwartz,Liang Cheng,Mahmut Akgul,María García-Martos,Manju Aron,Maria Rosaria Raspollini,Manuel Manrique Celada,Michael Hwang,Nathalie Rioux-Leclercq,Nicole Zalles,Norge Vergara,Priti Lal,Sara Wobker,Solène-Florence Kammerer-Jacquet,Susan Prendeville,Théau Tilmant,Virginie Verkarre,Katrina Collins,Angel Panizo,Luiz M. Nova-Camacho,Andres M. Acosta,Ankur R. Sangoi,Christopher DM. Fletcher,Matthew B. Palmer,Muhammad T. Idrees,Thomas M. Ulbright,Sean R. Williamson
DOI: https://doi.org/10.1016/j.humpath.2023.06.002
IF: 3.526
2023-06-18
Human Pathology
Abstract:Aims To elucidate the spectrum of metastatic solid tumors to the testis and their clinicopathologic features. Methods The databases and files of 26 pathology departments from 9 countries on 3 continents were surveyed to identify metastatic solid tumors to the testis and to characterize their clinicopathologic features in detail. Results We compiled a series of 157 cases of metastatic solid tumors that secondarily involved the testis. The mean patient age at diagnosis was 64 years (range, 12 to 93 years). Most patients (127/144; 88%) had clinical manifestation of the disease, with testicular mass/nodule (89/127; 70%) being the most common finding. The main mechanism of testicular involvement was metastasis in 154/157 (98%) cases. Bilateral testicular involvement was present in 12/157 (8%) patients. Concurrent or prior extratesticular metastases were present in 78/101 (77%) patients. The diagnosis was made mainly in orchiectomy specimens (150/157; 95%). Different types of carcinomas (138/157; 87%), most commonly adenocarcinoma (72/157; 46%), were the most common malignancies. The most common primary carcinomas included prostatic (51/149; 34%), renal (29/149; 20%), and colorectal (13/149; 9%). Intratubular growth was identified in 13/124 (11%) cases and paratesticular involvement was found in 73/152 (48%) cases. In patients with available follow-up (110/157; 70%), more than half (58/110; 53%) died of disease. Conclusion In this largest series compiled to date, we found that most secondary tumors of the testis represent metastases from the genitourinary and gastrointestinal tract carcinomas and typically occur in the setting of disseminated disease. Clinical trial registration No.
pathology